source
- STAT+: Rare disease drugmakers try to avoid Trump price cutsPlus, GOP voters want a crackdown on health care fraud, and how PBMs are skirting state laws.STAT · 9d ago↗ source
- Agios scraps sickle cell drugThe study failure costs Agios a chance to one-up Novo Nordisk and represents yet another setback in a disease that’s frustrated drugmakers of late.BioPharma Dive · 9d ago↗ source
- Novo sues Lilly, alleging ‘misleading’ advertising of obesity drugsThe lawsuit follows a cease-and-desist request and argues Lilly is using “deceptive” ads to claim its GLP-1 products are broadly superior to Novo’s medicines. Lilly countered that its campaign is “…BioPharma Dive · 9d ago↗ source